These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 148121)

  • 1. Improved sensitivity of chromogenic substrate assays for urokinase and plasmin.
    Friedman RB; Kwaan HC; Szczecinski M
    Thromb Res; 1978 Jan; 12(1):37-46. PubMed ID: 148121
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorescence polarization assay of plasmin, plasminogen, and plasminogen activator.
    Kinoshita K; Maeda H; Hinuma Y
    Anal Biochem; 1980 May; 104(1):15-22. PubMed ID: 6446247
    [No Abstract]   [Full Text] [Related]  

  • 3. [New methods of studying the plasmin system using azofibrin].
    Monastyrskiĭ VA; Gaĭda AV; Danysh TV; Magerovskiĭ IuV
    Lab Delo; 1988; (10):49-53. PubMed ID: 2462090
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion of Glu-plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):437-43. PubMed ID: 6457415
    [No Abstract]   [Full Text] [Related]  

  • 5. A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using a para-nitroanilide synthetic peptide substrate.
    Kulisek ES; Holm SE; Johnston KH
    Anal Biochem; 1989 Feb; 177(1):78-84. PubMed ID: 2525884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on tissue culture plasminogen activator. II. The detection and assay of urokinase and plasminogen activator from LLC-PK cultures (porcine) by the synthetic substrate Nalpha-benzyloxycarbonyl-glycyl-glycyl-arginyl-4-methoxy-2-napthylamide.
    Huseby RM; Clavin SA; Smith RE; Hull RN; Smithwick EL
    Thromb Res; 1977 May; 10(5):679-87. PubMed ID: 882957
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitive radiochemical esterolytic assays for urokinase.
    Imanari T; Wilcox GM; Pisano JJ
    Clin Chim Acta; 1976 Sep; 71(2):267-76. PubMed ID: 9214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.
    Karlan BY; Clark AS; Littlefield BA
    Biochem Biophys Res Commun; 1987 Jan; 142(1):147-54. PubMed ID: 3101684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive fluorescence assays for urokinase using synthetic peptide 4-methoxy-beta-naphthylamide substrates.
    Bigbee WL; Weintraub HB; Jensen RH
    Anal Biochem; 1978 Jul; 88(1):114-22. PubMed ID: 696991
    [No Abstract]   [Full Text] [Related]  

  • 10. Variation in assays of standard SK and plasmin preparations: evidence for and effect of variability of plasmins, plasminogen, and fibrinogen.
    Johnson AJ; Tse A; Skoza L
    Fed Proc; 1966; 25(1):34-41. PubMed ID: 4283648
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of substrates with 7-amino-3-trifluoromethylcoumarine (AFC) leaving group in the localization of protease activities in situ.
    Lojda Z
    Acta Histochem; 1996 Apr; 98(2):215-28. PubMed ID: 8739306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative properties of native and modified forms of urokinase.
    Toki N; Takasugi S; Sumi H; Kosugi T; Matsuo O; Mihara H
    Nihon Seirigaku Zasshi; 1981; 43(10):479-81. PubMed ID: 7038096
    [No Abstract]   [Full Text] [Related]  

  • 13. Dysfunctional plasminogen in full term newborn--study of active site of plasmin.
    Benavent A; Estellés A; Aznar J; Martinez-Sales V; Gilabert J; Fornas E
    Thromb Haemost; 1984 Feb; 51(1):67-70. PubMed ID: 6232730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasminogen determination, using a chromogenic tripeptidic substrate (author's transl)].
    Soria J; Soria C; Samama M
    Pathol Biol (Paris); 1976 Dec; 24(10):725-9. PubMed ID: 138119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay method for single-chain urokinase-type plasminogen activator.
    Matsuo O; Ueshima S; Okada K; Fukao H; Ohgaki M; Watanabe R; Arimura H
    Hematol Pathol; 1989; 3(3):137-42. PubMed ID: 2531734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct photometric or fluorometric assay of proteinases using substrates containing 7-amino-4-trifluoromethylcoumarin.
    Smith RE; Bissell ER; Mitchell AR; Pearson KW
    Thromb Res; 1980 Feb 1-15; 17(3-4):393-402. PubMed ID: 6445094
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmin potency estimates: influence of the substrate used in assay.
    Philo RD; Gaffney PJ
    Thromb Haemost; 1981 Apr; 45(2):107-9. PubMed ID: 6454987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium effects on the kinetics of human plasmin.
    Yang H
    Thromb Res; 1992 Feb; 65(3):377-88. PubMed ID: 1385909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urokinase-type plasminogen activator (uPA) and its inhibitor--new prognostic factors in oral squamous cell carcinoma].
    Geleţu G; Plămădeală P; Gogălniceanu D; Zeilhofer HF; Popescu E; Moscalu M
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):79-84. PubMed ID: 15688761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.